Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
Add more filters










Publication year range
1.
Andrology ; 2024 Mar 14.
Article in English | MEDLINE | ID: mdl-38483023

ABSTRACT

BACKGROUND: After the Coronavirus Disease pandemic, depression became more present, including in adolescents. Escitalopram, a selective serotonin reuptake inhibitor, was approved in 2009 for treatment of the major depressive disorder, both in children and adolescents. The undesirable effects of antidepressants on sexual dysfunction are usually underestimated. AIMS: To investigate the effects of chronic mild stress, induced from peripuberty up to adulthood, on male sexual behavior parameters, with or without the escitalopram treatment, using rats as experimental model in a translational study. MATERIALS AND METHODS: Forty-four peripubertal male rats were distributed into four groups: Sham control, escitalopram, stress, and stress + escitalopram. The chronic mild stress consisted of nine different stressors randomly applied one per day, for 8 weeks (from 41 to 97 days postpartum). Escitalopram therapy by gavage (10 mg/kg) started at 70 days postpartum and lasted for 4 weeks. The male sexual behavior parameters were evaluated at 114 days postpartum. After that, euthanasia was performed for blood and testis collection. Histopathology of the testes and plasmatic testosterone level were carried out. RESULTS: There was a reduction in sexual activity and motivation in rats exposed to the stress protocol, which were treated or not with escitalopram, as well as an increase in the total number of mounts in animals exposed to the stress and treated with escitalopram. The testosterone levels were lower in animals exposed to the stress, which were or not treated with escitalopram (stress and stress + escitalopram). The frequency of histologically normal seminiferous tubule sections was lower in animals that were exposed to the stress and/or received escitalopram (escitalopram, stress, and stress + escitalopram). CONCLUSION: Chronic mild stress induced from peripuberty, associated or not to escitalopram treatment, altered the testosterone levels and testicular histoarchitecture and seems to be related to the reduction in male sexual motivation.

2.
Andrology ; 11(1): 177-195, 2023 01.
Article in English | MEDLINE | ID: mdl-36334023

ABSTRACT

BACKGROUND: The prevalence of depression in adolescents has significantly increased worldwide. Escitalopram is a selective serotonin reuptake inhibitor approved for treatment of psychiatric disorders in children and adolescents by the Food and Drugs Administration. AIMS: This study aimed to evaluate the sperm parameters of adult rats exposed to chronic mild stress (CMS), from peripuberty to adulthood, treated or not with escitalopram. MATERIALS AND METHODS: Sixty-two male rats were distributed into four groups: S - submitted to CMS; E - Escitalopram (10 mg / kg, via gavage); ES - CMS + ES; SC - Sham control. The induced depression protocol consisted of the exposure of the animals to nine different stressors (one stressor/day), randomly for 8 weeks, from peripuberty (41 days postpartum, dpp) to adulthood (97 dpp). The escitalopram treatment period started at 70 dpp and lasted 4 weeks. The euthanasia was performed for biological material collection at 114 dpp. Morphometric, biometric, sperm parameters, oxidative stress analyses, and corticosterone dosage were carried out. RESULTS: There was a reduction of the sperm daily production and sperm concentration in the epididymis of rats treated and/or submitted to CMS. These groups (E, S, ES) also showed reduction of the mitochondrial activity; acrosome integrity; sperm chromatin compaction; sperm motility and vitality, besides an increased frequency of morphologically abnormal sperm. The sperm transit time through the epididymis was significantly higher in the escitalopram-treated rats (E, ES). No differences were observed regarding the sperm DNA fragmentation. The lipid peroxidation was significantly increased at the epididymal (E, S, and ES group) and testicular levels (S group). CONCLUSION: The CMS with or without escitalopram treatment altered the oxidative status in sperm and male organs, worsening the qualitative and quantitative sperm parameters, which can probably compromise the male fertility.


Subject(s)
Escitalopram , Sperm Motility , Female , Rats , Male , Animals , Rats, Wistar , Semen , Spermatozoa , Epididymis , Oxidative Stress
3.
Andrology ; 10(8): 1632-1643, 2022 11.
Article in English | MEDLINE | ID: mdl-36029003

ABSTRACT

BACKGROUND: Methylphenidate hydrochloride (MPH) is a psychostimulant widely used in the treatment of attention-deficit hyperactive disorder (ADHD), as well as a performance enhancer, for at least 60 years. Despite the notable effectiveness as a psychostimulant, ADHD is a chronic disorder and has a two-third chance of accompanying the individual throughout life. Long-term use of MPH has been associated not only with an increase in the development of neurodegenerative diseases, but it also causes side effects on male fertility in experimental animals. OBJECTIVES: To investigate whether methylphenidate poses a risk to sperm DNA structure and to the quality of embryos conceived after treatment during adolescence in rats. MATERIALS AND METHODS: Wistar rats at 38 days of age were treated either with 5 mg/kg body weight of MPH, in a single daily dose for 30 days, via gavage or with distilled water-only protocol. Levels of oxidative stress in testicular and epididymal tissues were evaluated. Sperm chromatin quality and acrosome integrity was assessed under flow cytometry. From 107 days of age, animals were mated with untreated females. The effects of the paternal contribution at two different embryo development moments-cleavage stage (2.5 days post coitum) and late gestation (20 days post coitum) -were analyzed. RESULTS: MPH caused high levels of sperm DNA damage, which was reflected in 40% of decrease in early embryo quality and a lower number of live pups at 20 dpc. DISCUSSION: The high level of fragmentation seen in the embryos sired from the MPH group is consistent with the poor chromatin structure of the sperm and does not seem to be a result of oxidative stress in the reproductive tissues. CONCLUSIONS: The results presented here suggest that the subchronic use of MPH during male prepubertal phase may cause long-term subfertility and compromise embryo survival.


Subject(s)
Central Nervous System Stimulants , Infertility , Methylphenidate , Animals , Central Nervous System Stimulants/toxicity , Chromatin , Female , Male , Methylphenidate/toxicity , Pregnancy , Rats , Rats, Wistar , Semen , Spermatozoa , Water
4.
Andrology ; 10(5): 951-972, 2022 07.
Article in English | MEDLINE | ID: mdl-35472028

ABSTRACT

BACKGROUND: Nicotine leads to reproductive changes culminating in male infertility and subfertility. Resveratrol, a polyphenol, is a biological modulator. Sirtuin 1 (SIRT1) protein can positively act on male reproduction, and its expression can be affected by nicotine and modulated by resveratrol. OBJECTIVES: The capability of resveratrol to reverse the reproductive damage in adult male offspring, which was nicotine-exposed during the intrauterine phase and breastfeeding, was investigated. MATERIALS AND METHODS: Four groups were established with male offspring born from nicotine-exposed and non-exposed rat dams during pregnancy and lactation. Forty-eight male Wistar rats were distributed into four groups: sham control (SC), resveratrol (R), nicotine (N), and nicotine + resveratrol (NR). Rat dams of the N and NR offspring were exposed to nicotine (2 mg/kg/day) during pregnancy and lactation using a subcutaneously implanted minipump. The offspring of the R and NR groups received resveratrol (300 mg/kg of body weight, gavage) for 63 days from puberty. At 114 days of age, the male rats were euthanized. RESULTS: Nicotine did not alter the body weight, biometry of reproductive organs, or quantitative sperm parameters of adult offspring but caused an evident worsening of all sperm qualitative parameters studied. Daily treatment with resveratrol from puberty up to adulthood improved all qualitative sperm parameters significantly, leading some of them close to the control values. Resveratrol also improved the morphological integrity and expression of SIRT1 in the seminiferous epithelium of nicotine-exposed offspring. CONCLUSION AND DISCUSSION: Resveratrol reversed the male reproductive damage caused by nicotine. Nicotine crosses the blood-placental membrane and is present in the breast milk of mothers who smoke. Resveratrol restored the altered reproductive parameters in the male adult offspring that were nicotine-exposed during intrauterine life and breastfeeding. The epigenetic modulating action of resveratrol can be involved in this nicotine damage reversion. Resveratrol may be a promising candidate to be investigated regarding the adjuvant strategies in the treatment of male infertility.


Subject(s)
Infertility, Male , Nicotine , Prenatal Exposure Delayed Effects , Resveratrol , Adult , Animals , Body Weight , Female , Humans , Infertility, Male/chemically induced , Lactation , Male , Nicotine/adverse effects , Placenta , Pregnancy , Rats , Rats, Wistar , Reproduction , Resveratrol/pharmacology , Semen , Sirtuin 1
5.
Andrologia ; 54(6): e14417, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35297074

ABSTRACT

In varicocele, the main cause of sperm DNA damage is oxidative stress (OS). Resveratrol, a polyphenol with antioxidant properties, can protect cells from injuries caused by OS. We investigated the benefits of resveratrol against reproductive damage caused by experimental varicocele induced from peripuberty. Eighty peripubertal male rats were distributed into 4 groups: sham-control (S), varicocele (V), resveratrol (R) and varicocele treated with resveratrol (VR). Varicocele was induced through the partial ligature of the left renal vein. Resveratrol was given in a daily dose of 300 mg/kg body weight (gavage). Sperm samples were collected at 100 days of age for vitality, DNA fragmentation and chromatin protamination evaluations. OS analyses were carried out. Rats from all groups were mated with healthy primiparous females for evaluation of reproductive capacity and embryonic quality. The V group showed reduction of sperm vitality, altered chromatin protamination and sperm DNA integrity and high levels of OS. The VR group showed an improvement of oxidative status, sperm vitality, DNA integrity and chromatin structure, and an enhancement in the gestational index and embryonic quality. Therefore, we showed in this experimental model that resveratrol is a promising nutraceutical adjuvant and should be deeply studied to mitigate subfertility in varicocele.


Subject(s)
Infertility, Male , Varicocele , Animals , Chromatin , DNA , DNA Fragmentation , Female , Humans , Infertility, Male/drug therapy , Infertility, Male/etiology , Infertility, Male/prevention & control , Male , Rats , Rats, Wistar , Resveratrol/pharmacology , Resveratrol/therapeutic use , Sperm Count , Sperm Motility , Spermatozoa , Varicocele/complications , Varicocele/drug therapy
6.
Andrologia ; 52(9): e13657, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32478927

ABSTRACT

Carbamazepine (CBZ), an anticonvulsant drug, is used by pregnant women and crosses the placental barrier, reaching the embryo/foetus. CBZ inhibits testicular steroidogenesis and may lead to alterations in testicular development, spermatogenesis and male fertility. The purpose of this study was to evaluate the CBZ effects on testicular parameters in the neonatal and pubertal phases, as well as the spermatic parameters of pubertal rats, originated from dams treated during different periods of the pregnancy. Pregnant rats were treated with CBZ (20 mg/kg/day; intraperitoneal route), from 12-20 gestation day (GD) (CBZ12 group) and 15-20 GD (CBZ15 group). The testicular morphometric and stereological analysis of rats aged 4 and 63 days was performed. The oestradiol and testosterone plasmatic levels, as well as spermatic parameters, were achieved at 63 days. CBZ12 group showed a reduction in testicular weight and volume at 4 days post-partum (dpp); however, there was an increase in the seminiferous cords' length of the CBZ12 and CBZ15 groups. At 63 days, the CBZ12 group showed increases of the daily sperm production and damage in the seminiferous epithelium. The results suggest that CBZ interferes with the testis development and the establishment of the spermatogenic process, which can be detected in the puberty phase.


Subject(s)
Placenta , Spermatogenesis , Animals , Carbamazepine/toxicity , Female , Humans , Male , Pregnancy , Puberty , Rats , Spermatozoa , Testis
7.
J Histochem Cytochem ; 68(5): 327-342, 2020 05.
Article in English | MEDLINE | ID: mdl-32228279

ABSTRACT

The aim of this study was to investigate carnitine action against negative effects of etoposide on stem/progenitor spermatogonia and on sperm production. Carnitine (250 mg/kg body weight/day) and etoposide (5 mg/kg body weight/day) were administered from 25-days postpartum to 32-days postpartum. Testes were collected at 32-days postpartum, 64-days postpartum, and 127-days postpartum, and submitted to the immuno-labeling of UTF1, SOX2, and PLZF proteins to identify undifferentiated spermatogonia populations. At 127-days postpartum, sperm were collected for analysis. Carnitine+etoposide group showed a higher numerical density of spermatogonia labeled for all studied proteins at 64-days postpartum (critical age) compared to the etoposide group. Moreover, there was an improvement of spermatic parameters and sperm DNA integrity in rats of the carnitine+etoposide group in comparison with rats of the etoposide group. The results suggest that carnitine improves the self-renewal of undifferentiated spermatogonia and promotes a partial protection on them, alleviating the etoposide harmful late effects and leading to an enhancement of the sperm parameters in adulthood.


Subject(s)
Carnitine/pharmacology , Cell Self Renewal/drug effects , Etoposide/toxicity , Spermatogonia/cytology , Spermatogonia/drug effects , Animals , DNA Damage , Dose-Response Relationship, Drug , Male , Organ Size/drug effects , Promyelocytic Leukemia Zinc Finger Protein/metabolism , Rats , SOXB1 Transcription Factors/metabolism , Seminiferous Epithelium/drug effects , Seminiferous Epithelium/growth & development , Spermatogenesis/drug effects , Spermatogonia/metabolism , Testis/drug effects , Testis/growth & development , Transcription Factors/metabolism
8.
J Histochem Cytochem ; 68(3): 185-198, 2020 03.
Article in English | MEDLINE | ID: mdl-31984829

ABSTRACT

Idiopathic varicocele is closely associated with male infertility or subfertility. Sertoli cell is a very important regulator of spermatogenesis. We investigated the morphofunctional alterations in the Sertoli cell and its possible involvement in the establishment of testicular primary lesion in experimental left-sided varicocele, induced from peripuberty. Twenty-five male peripubertal rats (44 days postpartum [dpp]) were distributed into two groups: control (C) and varicocele (V). Experimental left varicocele was induced in rats through the partial ligature of the left renal vein. Euthanasia was performed at 100 dpp. Testicular histopathology and testosterone plasmatic level were evaluated. Transferrin and vimentin proteins were, respectively, used as immunomarkers of Sertoli cell function and structure. Significant reductions in vimentin and transferrin expressions were noticed in androgen-dependent stages (VII and VIII) of the seminiferous epithelium cycle in V rats; testosterone plasmatic level was also reduced. Bilateral testicular histopathological alterations were found in V rats, mainly massive germ cell desquamation. The histological damage and changes in protein expressions occurred bilaterally. The relevant impairment of the functional and structural characteristics of the Sertoli cell, together with the typical massive germ cell desquamation, indicates that Sertoli cell changes can primarily contribute to the significant testicular dysfunction associated with varicocele.


Subject(s)
Infertility, Male/etiology , Sertoli Cells/metabolism , Spermatogenesis/drug effects , Varicocele/etiology , Animals , Disease Models, Animal , Gene Expression Regulation , Germ Cells/metabolism , Heparin/pharmacology , Ligation , Male , Prognosis , Rats , Rats, Wistar , Renal Veins/metabolism , Testis/metabolism , Testosterone/pharmacology , Transferrin/genetics , Transferrin/metabolism , Vimentin/genetics , Vimentin/metabolism
9.
Article in English | MEDLINE | ID: mdl-31354617

ABSTRACT

Cimetidine, used as an anti-ulcer and adjuvant treatment in cancer therapy, causes disorders in the male reproductive tract, including steroidogenesis. However, its effect on sperm quality and male fertility has been poorly addressed. Since vitamin B12 has demonstrated to recover spermatogonia number and sperm concentration in cimetidine-treated rats, we evaluated the impact of cimetidine on sperm quality and fertility potential and whether vitamin B12 is able to prevent the harmful effect of this drug on steroidogenesis and sperm parameters. Adult male rats were treated for 52 consecutive days as follows: cimetidine group (100 mg/kg of cimetidine), cimetidine/vitamin B12 group (100 mg/kg of cimetidine + 3 µg vitamin B12), vitamin B12 group (3 µg vitamin B12) and control group (saline). Serum testosterone levels and immunofluorescence associated to western blot for detection of 17ß-HSD6 were performed. Sperm morphology and motility, mitochondrial activity, acrosome integrity, DNA integrity by Comet assay, lipid peroxidation as well as fertility potential were analyzed in all groups. Apoptotic spermatids were also evaluated by caspase-3 immunohistochemistry. In the cimetidine-treated animals, reduced serum testosterone levels, weak 17ß-HSD6 levels and impaired spermiogenesis were observed. Low sperm motility and mitochondrial activity were associated with high percentage of sperm tail abnormalities, and the percentage of spermatozoa with damaged acrosome and DNA fragmentation increased. MDA levels were normal in all groups, indicating that the cimetidine-induced changes are associated to androgenic failure. In conclusion, despite the fertility potential of rats was unaffected by the treatment, the sperm quality was significantly impaired. Therefore, considering a possible sperm-mediated transgenerational inheritance, the long term offspring health needs to be investigated. The administration of vitamin B12 to male rats prevents the androgenic failure and counteracts the damage inflicted by cimetidine upon sperm quality, indicating that this vitamin may be used as a therapeutic agent to maintain the androgenic status and the sperm quality in patients exposed to androgen disrupters.

10.
Int J Exp Pathol ; 98(6): 312-328, 2017 12.
Article in English | MEDLINE | ID: mdl-29285813

ABSTRACT

The progression of diabetes mellitus leads to several complications including overproduction of reactive oxygen species and reproductive alterations. As resveratrol (RES) is a powerful anti-oxidant and an anti-apoptotic compound, we hypothesized that side effects of type-1 diabetes (DM1) on male reproduction could be reduced by the RES treatment. Eighty-four prepubertal male rats were distributed into seven groups: sham-control (SC), RES-treated (R), resveratrol-vehicle-treated (RV), diabetic (D), diabetic-insulin-treated (DI), diabetic-RES-treated (DR), diabetic-insulin and RES-treated (DIR). DM1 was induced by a single intraperitoneal streptozotocin (STZ) injection (65 mg/kg) on the 30th day postpartum (dpp). Animals of DR, DIR and R groups received 150 mg/day of RES by gavage for 43 consecutive days (from the 33 to 75 dpp). DI and DIR rats received subcutaneous injections of insulin (1 U/100 g b.w./day) from 5th day after the DM1 induction. The blood glucose level was monitored. At 75 dpp, the euthanasia was performed for morphometric and biometric testicular analyses, spermatic evaluation and hormonal doses. In the D group, the blood glucose level was higher than in the DR, DI and DIR groups. Besides morphometric testicular measurements, testosterone and estradiol doses were lower in D group than in DR and DIR groups; LH dose was also lower than in DR. The preputial separation age was delayed in diabetes-induced groups. The DR and DIR groups showed an improvement in sperm mitochondrial activity, epididymal sperm counts and the frequency of morphologically normal sperms. RES treatment improved glycaemic level, sperm quantitative and qualitative parameters and the hormonal profile in DM1-induced rats and seems to be a good reproductive protector.


Subject(s)
Diabetes Mellitus, Type 1/drug therapy , Spermatozoa/drug effects , Stilbenes/pharmacology , Testis/drug effects , Animals , Blood Glucose/metabolism , Diabetes Mellitus, Experimental , Disease Models, Animal , Epididymis/drug effects , Male , Oxidative Stress/drug effects , Rats, Wistar , Reactive Oxygen Species/metabolism , Reproduction/drug effects , Resveratrol , Sperm Motility/drug effects
11.
Reproduction ; 152(1): 23-35, 2016 07.
Article in English | MEDLINE | ID: mdl-27069006

ABSTRACT

The aim of this study was to investigate the protective action of resveratrol against the reproductive damage caused by left-sided experimental varicocele. There was a reduction of testicular major axis in the varicocele group when compared with the other groups; the testicular volume was reduced in varicocele group in comparison to the sham-control and resveratrol groups. The frequency of morphologically abnormal sperm was higher in varicocele and varicocele treated with resveratrol groups than in sham-control and resveratrol groups. The frequency of sperm with 100% of mitochondrial activity and normal acrosome integrity were lower in varicocele group than in varicocele treated with resveratrol, sham-control and resveratrol groups. Sperm motility was also reduced in varicocele group than in other groups. The sperm DNA fragmentation was higher in varicocele group than in other groups. Testicular levels of malondialdehyde were higher in varicocele and varicocele treated with resveratrol groups. The varicocele and varicocele treated with resveratrol groups had a significantly higher frequency of TUNEL-positive cells than sham-control and resveratrol groups; however, immunolabeling of the testes from varicocele treated with resveratrol group showed a lower number of apoptotic germ cells in comparison with the left testis of rats of the varicocele group. Reproductive alterations produced by varicocele from peripuberty were reduced by resveratrol in adulthood. Resveratrol should be better investigated as an adjuvant in the treatment of varicocele. Daily administration of resveratrol to rats with varicocele from peripuberty improves sperm quality in the adulthood.


Subject(s)
Infertility, Male/prevention & control , Puberty/physiology , Reproduction/physiology , Sperm Motility/drug effects , Stilbenes/pharmacology , Testis/physiology , Varicocele , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Male , Rats , Rats, Wistar , Resveratrol , Testis/drug effects
12.
Vet Clin Pathol ; 42(4): 483-9, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24111897

ABSTRACT

BACKGROUND: During pregnancy, glucocorticoids are frequently used to accelerate fetal lung maturation in preterm delivery. However, prenatal administration of glucocorticoids has been shown to affect organs such as fetal liver, an important hematopoietic organ during fetal development. OBJECTIVE: The aim of this study was to document the qualitative and quantitative changes in erythroid and megakaryocytic cell populations found in fetal livers as well as the hematology profile in neonates after maternal glucocorticoid treatment in rats. METHODS: Pregnant female Wistar rats were treated with dexamethasone 21-phosphate from days 13 to 16 of gestation. On the 17th day of pregnancy, the fetuses were collected and their livers processed for light and transmission electron microscopy. Glycol methacrylate-embedded sections were stained with PAS to determine the erythroblast and megakaryocytic cell frequencies. Fetal liver pieces embedded in Spurr resin were analyzed by transmission electron microscopy for morphologic changes. A standard hematology profile was evaluated in neonatal rats. RESULTS: In the fetuses from treated dams, the total cell number of erythroid cells in livers was significantly reduced compared to control fetuses (P < .001), but erythroblasts did not present ultrastructural abnormalities. The degree of maturation in the megakaryocyte series tended to be increased. In neonates, there were elevated numbers of nucleated RBCs (P = .002), along with a higher HCT and HGB (P = .02). In addition, the platelet concentration was also significantly increased (P < .007). CONCLUSION: These results suggest that maternal dexamethasone treatment has quantitative effects on erythroid and megakaryocytic cells in fetal liver and the neonatal hematology profile in rats.


Subject(s)
Dexamethasone/analogs & derivatives , Fetal Development/drug effects , Glucocorticoids/adverse effects , Liver/drug effects , Animals , Animals, Newborn , Blood Platelets/drug effects , Dexamethasone/adverse effects , Dexamethasone/therapeutic use , Erythroblasts/drug effects , Erythropoiesis/drug effects , Female , Glucocorticoids/therapeutic use , Hematologic Tests/veterinary , Maternal-Fetal Exchange , Megakaryocytes/drug effects , Microscopy, Electron, Transmission/veterinary , Pregnancy , Rats , Rats, Wistar
13.
Cell Tissue Res ; 337(2): 269-80, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19444474

ABSTRACT

Etoposide is a chemotherapeutic agent that induces cell death by blocking topoisomerase II catalytic function. Although etoposide is effective in the treatment of cancer, it also causes the death of normal proliferating cells, including male germ cells. Administration of etoposide during the prepubertal phase causes diturbances in several testicular morphometric parameters and in Sertoli cells. Cytoprotection of the seminiferous epithelium is the only means of preserving potential male reproduction in prepubertal cancer patients. Carnitine, an amino acid naturally present in normal cells, is a promising cryoprotectant as it is concentrated in the epididymis and promotes sperm maturation. We have therefore investigated whether carnitine protects rat testes against etoposide and, thus, improves fertility in adulthood. Our results suggest that carnitine partially protects the testis against damage caused by etoposide, although the mechanism by which it happens remains unknown.


Subject(s)
Antineoplastic Agents, Phytogenic/adverse effects , Carnitine/pharmacology , Cytoprotection , Etoposide/adverse effects , Testis/drug effects , Vitamin B Complex/pharmacology , Animals , Male , Rats , Rats, Wistar , Spermatozoa/cytology , Spermatozoa/drug effects , Testis/cytology
14.
Int J Androl ; 32(5): 563-74, 2009 Oct.
Article in English | MEDLINE | ID: mdl-18637155

ABSTRACT

Carbamazepine (CBZ) is a first-line antiepileptic drug (AED), although it is also utilized for treatment of psychiatric disorders and neuropathic pain. The utilization of CBZ has been associated with damage to male reproduction including hormonal alterations, sexual dysfunction and reduction of sperm quality. Wide and long-term use of CBZ has been a common schedule for children and adolescents, despite the fact it alters the testosterone level in adult rats and humans. In addition, hypothalamic-pituitary-gonadal (HPG) axis during pre-puberty and puberty is more susceptible to toxic agents than in adult phase. The objective of this work was to evaluate the side effects of CBZ on the spermatogenic process of rats from pre-puberty to puberty and sexual maturation. Damage on the seminiferous epithelium, testicular interstitial oedema, reductions of testosterone levels and an increase in oestradiol levels were observed in rats, which were CBZ-treated since the weaning. The results suggest that CBZ, when administered from pre-puberty, provokes specific side effects on rat testes, resulting in more severe damage in the adult phase.


Subject(s)
Anticonvulsants/pharmacology , Carbamazepine/pharmacology , Spermatogenesis/drug effects , Animals , Male , Rats , Rats, Wistar
15.
Anat Rec (Hoboken) ; 291(7): 797-808, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18543292

ABSTRACT

Cisplatin is a potent drug used in clinical oncology but causes spermatogenesis damage. Amifostine is a drug used against toxicity caused by ionizing irradiation and chemotherapeutic drugs. Since cisplatin provokes fertility and induces germ cell apoptosis and necrosis, we proposed to evaluate the amifostine cytoprotective action on testes of cisplatin-treated rats. Thirty-day-old prepubertal Wistar rats received a single cisplatin dose of 5 mg/kg and were killed after 3, 6, and 12 hr. The hematoxylin-eosin stained testicular sections were submitted to histological, morphometric, and stereological analysis. The terminal deoxynucleotidyl transferase-mediated deoxyuridinetriphosphate nick end-labeling (TUNEL) method was used to label apoptotic cells. TUNEL-positive and TUNEL-negative germ cells with abnormal nuclear morphology (ANM) were scored. Significant alterations of greater part of the parameters occurred in the cisplatin-treated group (CE) compared to the group that received amifostine before the cisplatin-treatment (ACE); however, testicular weight and volume did not vary between these groups. Tubular diameter was reduced in CE in comparison to ACE rats, while interstitial tissue and lymphatic space volume and volume density were significantly higher in CE rats; interstitial testicular edema probably occurred in cisplatin-treated rats. CE rats showed important histological alterations, which were more accentuated than in ACE rats. The numerical densities of apoptotic germ cells and TUNEL-negative cells with ANM were lower in ACE than in CE rats. In conclusion, the amifostine previously administered to prepubertal rats reduced the testicular damage caused by cisplatin. We conclude that amifostine partially protected the rat seminiferous epithelium against cisplatin toxicity.


Subject(s)
Amifostine/pharmacology , Antineoplastic Agents/antagonists & inhibitors , Antineoplastic Agents/toxicity , Cisplatin/antagonists & inhibitors , Cisplatin/toxicity , Testis/drug effects , Animals , Apoptosis/drug effects , In Situ Nick-End Labeling , Male , Protective Agents/pharmacology , Rats , Rats, Wistar , Seminiferous Epithelium/drug effects , Seminiferous Epithelium/pathology , Spermatogenesis/drug effects , Testis/pathology
16.
J Anat ; 209(1): 21-9, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16822266

ABSTRACT

In the bullfrog Rana catesbeiana, testicular weight is constant throughout the year, but the volume densities of germinative and interstitial compartments undergo inverse changes from winter (non-breeding) to summer (breeding). The occurrence of apoptosis in the seminiferous lobules of bullfrogs was investigated in these two periods using sections stained with haematoxylin and eosin (H&E), the TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick end labelling) method and transmission electron microscopy. TUNEL-positive cells were observed in the seminiferous lobules, and ultrastructural morphological details confirmed the occurrence of cell death by apoptosis. In summer, the occurrence of several spermatogenic processes (in addition to spermiogenesis and spermiation), and then the overconsumption of Sertoli cell-derived pro-survival factors, could be responsible for the increased density of apoptotic cells. Alternatively, the low apoptotic frequency in winter could be related to the constant homeostasis in the germinative compartment given that most lobules are filled with primary spermatocytes. As volume densities of interstitial and germinative compartments undergo inverse seasonal variations through the year, the incidence of apoptosis (in summer) could play a part in controlling the spermatogenic process, maintaining the lobular size when interstitial tissue is maximally developed. In winter, the low apoptotic cell density leads to spermatogenic recrudescence and, thereby, the production of an adequate quantity of spermatozoa for the next breeding period. Thus, apoptosis may participate not only in the maintenance of spermatogenic homeostasis, but also in the cyclical control of the different spermatogenic processes according to seasonal changes of the testicular compartments as a whole.


Subject(s)
Rana catesbeiana/physiology , Seasons , Spermatogenesis/physiology , Spermatozoa/cytology , Testis/anatomy & histology , Animals , Apoptosis , DNA Fragmentation , In Situ Nick-End Labeling , Male , Microscopy, Electron, Transmission , Seminiferous Tubules/anatomy & histology , Spermatozoa/ultrastructure , Staining and Labeling
17.
Histochem Cell Biol ; 126(3): 353-61, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16550346

ABSTRACT

Sertoli cell plays a key role in spermatogenesis. Many studies refer that this cell is not harmed by the majority of anticancer treatments known to cause damage to the testis. However, in the previous study we observed that etoposide, an efficient chemotherapeutic drug, provokes an increase in numerical density of the Sertoli cells. This phenomenon suggests that this cell was harmed by etoposide. Thus, we decided to investigate a possible direct action of etoposide on Sertoli cells analyzing the function of this cell and relating it with the integrity and damage of the seminiferous epithelium. Prepubertal albino rats received 5 mg/kg of etoposide for eight consecutive days and were sacrificed in different ages. The control groups received 0.9% saline solution. The testes were fixed in Bouin's liquid for transferrin immunolabeling and testicular labeled tissue volume density measurement. Except for the younger rats, all the etoposide-treated rats showed diminution of transferrin immunolabeling in the seminiferous epithelium, and consequently, of total labeled testicular tissue volume density. We concluded that the diminution of transferrin labeling in the seminiferous epithelium was not associated with germ cell absence such as commonly reported. The results suggest etoposide impairs Sertoli cell function.


Subject(s)
Etoposide/pharmacology , Seminiferous Epithelium/drug effects , Seminiferous Tubules/drug effects , Sertoli Cells/physiology , Sexual Maturation , Animals , Immunohistochemistry , Male , Rats , Rats, Wistar , Sertoli Cells/drug effects , Transferrin/analysis
18.
Anat Rec A Discov Mol Cell Evol Biol ; 279(1): 611-22, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15224403

ABSTRACT

Etoposide is a podophyllotoxin semiderivative that is used in a variety of chemotherapy treatments, including therapy for children tumors. This drug promotes the formation of a ternary DNA-topoisomerase II-etoposide complex that triggers apoptosis. The purpose of this work was to analyze the occurrence of apoptosis in the seminiferous epithelium of prepubertal, pubertal, and adult rats treated with 10, 20, and 40 mg/Kg of etoposide during the prepubertal phase, as well as the role of apoptosis in etoposide-induced testicular damage. The rat testes were fixed in Bouin's liquid, and the apoptotic cells were quantified by means of the hematoxylin and eosin (H&E) technique (all groups) and the terminal dUTP nick end labeling (TUNEL) method (prepubertal groups only). The results obtained from both the H&E and TUNEL methods showed an increased frequency of apoptosis in the seminiferous epithelium of treated animals, except for the subgroup that received the 10-mg/Kg dose and was sacrificed 12 hr after the treatment and for the etoposide-treated pubertal group, that did not show cells suggesting apoptosis during H&E analysis. The labeled cells were mainly primary spermatocytes and differentiated spermatogonia. The prepubertal rats showed an etoposide-dose-dependent diminution of differentiated spermatogonia. Etoposide treatment during the prepubertal phase increases the frequency of apoptosis in the seminiferous epithelium, and causes serious harm to male fertility. 2004.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Apoptosis/drug effects , Etoposide/pharmacology , Sexual Maturation , Testis/drug effects , Testis/pathology , Animals , Antineoplastic Agents, Phytogenic/administration & dosage , Body Weight/drug effects , Cell Count , Dose-Response Relationship, Drug , Epithelium/drug effects , Epithelium/pathology , Etoposide/administration & dosage , Female , Fertility/drug effects , Male , Rats , Rats, Wistar , Seminiferous Tubules/drug effects , Seminiferous Tubules/pathology , Sertoli Cells/drug effects , Sertoli Cells/pathology , Spermatogonia/drug effects
19.
Rev. bras. ciênc. morfol ; 7(1): 8-15, jan.-jun. 1990. tab, ilus
Article in Portuguese | LILACS | ID: lil-114114

ABSTRACT

Foi realizado, ao microscópio óptico comum, estudo histomorfométrico comparativo de testículos de ratos albinos normais, em várias idades, na fase pós-natal, desde a imaturidade até a idade adulta. Efetuaram-se medidas de peso dos testículos, e calcularam-se os volumes totais dos testículos, dos túbulos seminíferos de cada testículo bem como do tecido intersticial. As lâminas, contendo as secçöes tansversais das gônadas masculinas, preparadas segundo os procedimentos normais de inclusäo em parafina, foram coradas utilizando-se o método do Acido Periódico-Schiff (PAS) e da Hematoxilina de Harris. Optou-se por esta técnica por ser aquela que melhor evidencia as fases da espermiogênese. Os resultados mostraram que animais com 15 dias de idade apresentam testículos contendo túbulos seminíferos cujo epitélio compöe-se, principalmente, de células de Sertoli e de espermatogônias, em grande parte indiferenciadas. A partir dos 30 dias de idade observaram-se, nos túbulos seminíferos, espermátides nas fases precoses da espermiogênese, com características bem evidentes, porém em frequência baixa. Formaçöes binucleadas e multinucleadas de espermátides foram encontradas nos testículos de ratos imaturos normais


Subject(s)
Animals , Rats , Histology , Seminiferous Tubules , Spermatogenesis , Testis
20.
Rev. bras. ciênc. morfol ; 6(1): 14-20, jan.-jun. 1989. ilus
Article in Portuguese | LILACS | ID: lil-94947

ABSTRACT

Foram efetuados estudos citológicos das formaçöes multinucleadas de espermátides, aos microscópios óptico e eletrônico, em testículos de ratos albinos da linhagem Wistar, submetidos a fonte externa de calor por período de tempo pré-determinado. As formaçöes multinucleadas apresentam organizaçöes peculiares tanto do núcleo como do citoplasma e alteraçöes dos acrossomas. A presença dessas formaçöes ocorre em situaçöes em que se observa degeneraçäo das células do epitélio seminífero. Contudo, no compartimento adluminar dos túbulos seminíferos as formaçöes multinucleadas acabam degenerando. Elas resultam da confluência das membranas citoplasmáticas das espermátides em fase acrossômica e de capuz cefálico, por defeitos nas pontes intercelulares que as conectam, o que leva ao aparecimento de verdadeiros "clones celulares"


Subject(s)
Animals , Male , Spermatids/ultrastructure , Cell Nucleus/ultrastructure , Rats/anatomy & histology , Seminiferous Tubules/cytology , Rats, Inbred Strains
SELECTION OF CITATIONS
SEARCH DETAIL
...